Helicobacter Pylori (H. Pylori) Non-invasive Testing Market

Helicobacter Pylori (H. Pylori) Non-invasive Testing Market (Test Type: Serology Test, Stool Antigen Test, and Urea Breath Test; and Test Method: Laboratory-based Tests and Point-of-Care Tests) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Outlook 2031

  • The industry was valued at US$ 549.6 Mn in 2022
  • It is estimated to grow at a CAGR of 4.2% from 2023 to 2031 and reach US$ 788.2 Mn by the end of 2031

Analyst Viewpoint

Rise in prevalence of H. pylori infection and advancements in PCR technology are fueling the Helicobacter pylori (H. pylori) non-invasive testing market size. Low diagnosis rates, asymptomatic nature of infection, and are expected to hamper the market landscape in the near future.

H. pylori infection is very common among children, particularly in developing countries and regions with poor sanitation and overcrowded living conditions.

Key players operating in the Helicobacter pylori (H. pylori) non-invasive testing market landscape are developing tests that offer quick and accurate results enabling healthcare professionals to make informed decisions about patient care.

Market Introduction

Helicobacter pylori (H. pylori) is a spiral-shaped gram-negative aerobic bacterium that infects the stomach. When H. pylori infects the stomach lining, it results in stomach infections.

Such infections generally lead to peptic ulcers and gastritis and are additionally associated with stomach, duodenal, and gastric cancers. This kind of infection is found in men, women, and even children. Over 50% of the world's population is infected by H. pylori.

Rise in Prevalence of H. Pylori Infections Fostering Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value

H. pylori infection is an asymptomatic infection that requires professional diagnosis. Peptic ulcers are usually caused due to H. pylori and some of the most common symptoms of the infection include vomiting, abdominal pain, nausea, loss of appetite, and excessive burping.

H. pylori infection is very common among children. In some cases, peptic ulcers lead to serious complications such as obstruction in the stomach lining, internal bleeding, or perforation.

According to a study published in the Journal of Family Medicine and Primary Care in 2022, the prevalence rates of H. pylori among male and female patients were 32.3% and 32.7%, respectively. The prevalence rate of H. pylori was highest among patients aged between 41 and 60 years (38.7%) and lowest among those aged over 60 years (19.5%).

The most important risk factors include being male, poor adherence or difficult access to treatment, and the lack of in-home water service. The prevalence of H. pylori in children without gastrointestinal who underwent screening was reported to be only 14.2% in Africa.

Some of the major factors are having a traditional pit or no toilet, poverty, birth order, source of drinking water, or being a farmer. These factors are expected to spur the Helicobacter pylori (H. pylori) non-invasive testing market growth in the near future.

Asia Pacific seems to have the widest variations in terms of H. pylori prevalence and is associated with as lower income and educational level, house crowding, rural residence, ethnicity, the use of tanks as water supplies, alcohol drinking, active smoking, eating spicy food or raw uncooked vegetables, and poor living conditions and sanitation.

Thus, absence of personal hygiene and poor sanitation are propelling the Helicobacter pylori (H. pylori) non-invasive testing market demand.

Advancements in PCR Technology Propelling Market Progress

Polymerase Chain Reaction (PCR) is largely employed to detect gastric biopsies, dental plaque, and feces to further improve invasive approaches for disease diagnosis. PCR enhances the diagnosis of H. pylori infection in non-bleeding conditions.

Development and launch of advanced PCR-based testing methods is driving the Helicobacter pylori (H. pylori) non-invasive testing industry expansion.

In 2020, Becton, Dickinson, and Company launched its new BD MAX H. pylori non-invasive molecular diagnostic test that employs PCR technology to detect H. pylori DNA in stool specimens. The test provides quick and accurate results, offering a highly efficient diagnostic tool for H. pylori infections.

Regional Outlook

According to latest Helicobacter pylori (H. pylori) non-invasive testing market trends, North America held the largest share in 2022. Increase in adoption of non-invasive testing methods and heightened prevalence of H. pylori infection are fueling the market dynamics of the region.

According to the Centers for Disease Control and Prevention, 35%-40% of the population in the U.S. is affected by H. pylori. Furthermore, approval of various non-invasive tests for the detection and diagnosis of H. pylori infections, including stool antigen tests and breath tests, are also bolstering the Helicobacter pylori (H. pylori) non-invasive testing market share in North America.

Analysis of Key Players in Helicobacter Pylori (H. Pylori) Non-invasive Testing Industry

Many individuals infected with H. pylori may not exhibit any symptoms. They may not seek medical attention, leading to underdiagnosis and undertreatment of the infection. This, in turn, is expected to limit the market revenue in the next few years.

To overcome these issues, government organizations and manufacturers of Helicobacter pylori (H. pylori) non-invasive testing solutions are promoting diseases awareness. Manufacturers are developing tests that offer quick and accurate results enabling healthcare professionals to make informed decisions about patient care.

DiaSorin S.p.A., Meridian Bioscience, Inc., Exalenz Bioscience Ltd., Abbott, Thermo Fisher Scientific, Biomerica, Inc., Certest Biotec S.L., Sekisui Diagnostics, Coris Bioconcept, and Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.

These companies have been profiled in the Helicobacter pylori (H. pylori) non-invasive testing market report based on various parameters including company overview, business segments, product portfolio, recent developments, business strategies, and financial overview.

Key Developments in Helicobacter Pylori (H. Pylori) Non-invasive Testing Market

  • In 2021, Abbott launched its new Alinity m Resp-4-Plex molecular non-invasive diagnostic tool for respiratory infections that includes detection of H. pylori DNA. This development is expected to expand testing capabilities of Abbott in the H. pylori non-invasive diagnostic tests market.

Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Snapshot

Attribute Detail
Market Size in 2022 US$ 549.6 Mn
Market Forecast (Value) in 2031 US$ 788.2 Mn
Growth Rate (CAGR) 4.2%
Forecast Period 2023-2031
Historical Data Available for 2017-2021
Quantitative Tons US$ Mn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy and recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • Test Type
    • Serology Test
    • Stool Antigen Test (SAT)
    • Urea Breath Test (UBT)
  • Test Method
    • Laboratory-based Tests
    • Point-of-Care Tests
  • End-user
    • Hospitals
    • Clinics
    • Diagnostic Laboratories
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Japan
  • China
  • India
  • Australia & New Zealand
  • Brazil
  • Mexico
  • South Africa
  • GCC Countries
Companies Profiled
  • DiaSorin S.p.A.
  • Meridian Bioscience, Inc.
  • Exalenz Bioscience Ltd.
  • Abbott
  • Thermo Fisher Scientific
  • Biomerica, Inc.
  • Certest Biotech S.L.
  • Sekisui Diagnostics
  • Coris Bioconcept
  • Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global Helicobacter pylori (H. Pylori) non-invasive testing market in 2022?

It was valued at US$ 549.6 Mn in 2022

How is the Helicobacter pylori (H. Pylori) non-invasive testing industry expected to grow during the forecast period?

It is anticipated to grow at a CAGR of 4.2% from 2023 to 2031

What are the key factors driving the demand for Helicobacter pylori (H. Pylori) non-invasive testing?

Rise in prevalence of H. Pylori infection and advancements in PCR technology

Which was the major region in the global Helicobacter pylori (H. Pylori) non-invasive testing landscape in 2022?

North America was the leading region in 2022

Who are the prominent Helicobacter pylori (H. Pylori) non-invasive testing manufacturers?

DiaSorin S.p.A., Meridian Bioscience, Inc., Exalenz Bioscience Ltd., Abbott, Thermo Fisher Scientific, Biomerica, Inc., Certest Biotec S.L., Sekisui Diagnostics, Coris Bioconcept, and Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

            4.1.2. Industry Evolution/Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast, 2017–2031

    5. Key Insights

        5.1. Pipeline Analysis

        5.2. Key Product/Brand Analysis

        5.3. Key Mergers & Acquisitions

        5.4. COVID-19 Pandemic Impact on Industry

    6. Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast, by Test Type

        6.1. Introduction & Definition

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Test Type, 2017–2031

            6.3.1. Serology Test

            6.3.2. Stool Antigen Test (SAT)

            6.3.3. Urea Breath Test (UBT)

        6.4. Market Attractiveness Analysis, by Test Type

    7. Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast, by Test Method

        7.1. Introduction & Definition

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by Test Method, 2017–2031

            7.3.1. Laboratory-based Tests

            7.3.2. Point-of-Care Tests

        7.4. Market Attractiveness Analysis, by Test Method

    8. Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast, by End-user

        8.1. Introduction & Definition

        8.2. Key Findings/Developments

        8.3. Market Value Forecast, by End-user, 2017–2031

            8.3.1. Hospitals

            8.3.2. Clinics

            8.3.3. Diagnostic Laboratories

        8.4. Market Attractiveness Analysis, by Test Method

    9. Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region, 2017–2031

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness Analysis, by Region

    10. North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast

        10.1. Introduction

        10.2. Key Findings

        10.3. Market Value Forecast, by Test Type, 2017–2031

            10.3.1. Serology Test

            10.3.2. Stool Antigen Test (SAT)

            10.3.3. Urea Breath Test (UBT)

        10.4. Market Value Forecast, by Test Method, 2017–2031

            10.4.1. Laboratory-based Tests

            10.4.2. Point-of-Care Tests

        10.5. Market Value Forecast, by End-user, 2017–2031

            10.5.1. Hospitals

            10.5.2. Clinics

            10.5.3. Diagnostic Laboratories

        10.6. Market Value Forecast, by Country, 2017–2031

            10.6.1. U.S.

            10.6.2. Canada

        10.7. Market Attractiveness Analysis

            10.7.1. By Test Type

            10.7.2. By Test Method

            10.7.3. By End-user

            10.7.4. By Country

    11. Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast

        11.1. Introduction

        11.2. Key Findings

        11.3. Market Value Forecast, by Test Type, 2017–2031

            11.3.1. Serology Test

            11.3.2. Stool Antigen Test (SAT)

            11.3.3. Urea Breath Test (UBT)

        11.4. Market Value Forecast, by Test Method, 2017–2031

            11.4.1. Laboratory-based Tests

            11.4.2. Point-of-Care Tests

        11.5. Market Value Forecast, by End-user, 2017–2031

            11.5.1. Hospitals

            11.5.2. Clinics

            11.5.3. Diagnostic Laboratories

        11.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.6.1. Germany

            11.6.2. U.K.

            11.6.3. France

            11.6.4. Italy

            11.6.5. Spain

            11.6.6. Rest of Europe

        11.7. Market Attractiveness Analysis

            11.7.1. By Test Type

            11.7.2. By Test Method

            11.7.3. By End-user

            11.7.4. By Country/Sub-region

    12. Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast

        12.1. Introduction

        12.2. Key Findings

        12.3. Market Value Forecast, by Test Type, 2017–2031

            12.3.1. Serology Test

            12.3.2. Stool Antigen Test (SAT)

            12.3.3. Urea Breath Test (UBT)

        12.4. Market Value Forecast, by Test Method, 2017–2031

            12.4.1. Laboratory-based Tests

            12.4.2. Point-of-Care Tests

        12.5. Market Value Forecast, by End-user, 2017–2031

            12.5.1. Hospitals

            12.5.2. Clinics

            12.5.3. Diagnostic Laboratories

        12.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.6.1. China

            12.6.2. Japan

            12.6.3. India

            12.6.4. Australia & New Zealand

            12.6.5. Rest of Asia Pacific

        12.7. Market Attractiveness Analysis

            12.7.1. By Test Type

            12.7.2. By Test Method

            12.7.3. By End-user

            12.7.4. By Country/Sub-region

    13. Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast

        13.1. Introduction

        13.2. Key Findings

        13.3. Market Value Forecast, by Test Type, 2017–2031

            13.3.1. Serology Test

            13.3.2. Stool Antigen Test (SAT)

            13.3.3. Urea Breath Test (UBT)

        13.4. Market Value Forecast, by Test Method, 2017–2031

            13.4.1. Laboratory-based Tests

            13.4.2. Point-of-Care Tests

        13.5. Market Value Forecast, by End-user, 2017–2031

            13.5.1. Hospitals

            13.5.2. Clinics

            13.5.3. Diagnostic Laboratories

        13.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.6.1. Brazil

            13.6.2. Mexico

            13.6.3. Rest of Latin America

        13.7. Market Attractiveness Analysis

            13.7.1. By Test Type

            13.7.2. By Test Method

            13.7.3. By End-user

            13.7.4. By Country/Sub-region

    14. Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Analysis and Forecast

        14.1. Introduction

        14.2. Key Findings

        14.3. Market Value Forecast, by Test Type, 2017–2031

            14.3.1. Serology Test

            14.3.2. Stool Antigen Test (SAT)

            14.3.3. Urea Breath Test (UBT)

        14.4. Market Value Forecast, by Test Method, 2017–2031

            14.4.1. Laboratory-based Tests

            14.4.2. Point-of-Care Tests

        14.5. Market Value Forecast, by End-user, 2017–2031

            14.5.1. Hospitals

            14.5.2. Clinics

            14.5.3. Diagnostic Laboratories

        14.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.6.1. GCC Countries

            14.6.2. South Africa

            14.6.3. Rest of Middle East & Africa

        14.7. Market Attractiveness Analysis

            14.7.1. By Test Type

            14.7.2. By Test Method

            14.7.3. By End-user

            14.7.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)

        15.2. Market Share Analysis, by Company (2022)

        15.3. Company Profiles

            15.3.1. DiaSorin S.p.A.

                15.3.1.1. Company Overview

                15.3.1.2. Product Portfolio

                15.3.1.3. SWOT Analysis

                15.3.1.4. Financial Overview

                15.3.1.5. Strategic Overview

            15.3.2. Meridian Bioscience, Inc.

                15.3.2.1. Company Overview

                15.3.2.2. Product Portfolio

                15.3.2.3. SWOT Analysis

                15.3.2.4. Financial Overview

                15.3.2.5. Strategic Overview

            15.3.3. Exalenz Bioscience Ltd.

                15.3.3.1. Company Overview

                15.3.3.2. Product Portfolio

                15.3.3.3. SWOT Analysis

                15.3.3.4. Financial Overview

                15.3.3.5. Strategic Overview

            15.3.4. Abbott

                15.3.4.1. Company Overview

                15.3.4.2. Product Portfolio

                15.3.4.3. SWOT Analysis

                15.3.4.4. Financial Overview

                15.3.4.5. Strategic Overview

            15.3.5. Thermo Fisher Scientific

                15.3.5.1. Company Overview

                15.3.5.2. Product Portfolio

                15.3.5.3. SWOT Analysis

                15.3.5.4. Financial Overview

                15.3.5.5. Strategic Overview

            15.3.6. Biomerica, Inc.

                15.3.6.1. Company Overview

                15.3.6.2. Product Portfolio

                15.3.6.3. SWOT Analysis

                15.3.6.4. Financial Overview

                15.3.6.5. Strategic Overview

            15.3.7. Certest Biotech S.L.

                15.3.7.1. Company Overview

                15.3.7.2. Product Portfolio

                15.3.7.3. SWOT Analysis

                15.3.7.4. Financial Overview

                15.3.7.5. Strategic Overview

            15.3.8. Sekisui Diagnostics

                15.3.8.1. Company Overview

                15.3.8.2. Product Portfolio

                15.3.8.3. SWOT Analysis

                15.3.8.4. Financial Overview

                15.3.8.5. Strategic Overview

            15.3.9. Coris Bioconcept

                15.3.9.1. Company Overview

                15.3.9.2. Product Portfolio

                15.3.9.3. SWOT Analysis

                15.3.9.4. Financial Overview

                15.3.9.5. Strategic Overview

            15.3.10. Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.

                15.3.10.1. Overview

                15.3.10.2. Product Portfolio

                15.3.10.3. SWOT Analysis

                15.3.10.4. Financial Overview

                15.3.10.5. Strategic Overview

    List of Tables

    Table 01: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2031

    Table 02: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Method, 2017–2031

    Table 03: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 04: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Region, 2017–2031

    Table 05: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Country, 2017–2031

    Table 06: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2031

    Table 07: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Method, 2017–2031

    Table 08: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 09: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 10: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2031

    Table 11: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Method, 2017–2031

    Table 12: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 13: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 14: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2031

    Table 15: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Method, 2017–2031

    Table 16: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 17: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 18: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2031

    Table 19: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Method, 2017–2031

    Table 20: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 21: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 22: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2031

    Table 23: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by Test Method, 2017–2031

    Table 24: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    List of Figures

    Figure 01: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031

    Figure 02: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn), by Test Type, 2022

    Figure 03: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by Test Type, 2022

    Figure 04: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn), by Test Method, 2022

    Figure 05: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by Test Method, 2022

    Figure 06: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn), by End-user, 2022

    Figure 07: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by End-user, 2022

    Figure 08: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by Region, 2022

    Figure 09: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value (US$ Mn) Forecast, 2023–2031

    Figure 10: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Type, 2022–2031

    Figure 11: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Type, 2023–2031

    Figure 12: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Method, 2022–2031

    Figure 13: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Method, 2023–2031

    Figure 14: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by End-user, 2022–2031

    Figure 15: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 16: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Region, 2022–2031

    Figure 17: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Region, 2022–2031

    Figure 18: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031

    Figure 19: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Country, 2023–2031

    Figure 20: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Country, 2022–2031

    Figure 21: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Type, 2022–2031

    Figure 22: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Method, 2022–2031

    Figure 23: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by End-user, 2022–2031

    Figure 24: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Type, 2023–2031

    Figure 25: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Method, 2023–2031

    Figure 26:North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 27: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031

    Figure 28: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 29: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 30: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Type, 2022–2031

    Figure 31: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Method, 2022–2031

    Figure 32: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by End-user, 2022–2031

    Figure 33: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Type, 2023–2031

    Figure 34: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Method, 2023–2031

    Figure 35: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 36: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031

    Figure 37: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 38: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 39: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Type, 2022–2031

    Figure 40: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Method, 2022–2031

    Figure 41: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by End-user, 2022–2031

    Figure 42: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Type, 2023–2031

    Figure 43: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Method, 2023–2031

    Figure 44: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 45: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031

    Figure 46: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 47: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 48: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Type, 2022–2031

    Figure 49: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Method, 2022–2031

    Figure 50: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by End-user, 2022–2031

    Figure 51: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Type, 2023–2031

    Figure 52: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Method, 2023–2031

    Figure 53: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 54: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031

    Figure 55: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 56: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 57: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Type, 2022–2031

    Figure 58: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by Test Method, 2022–2031

    Figure 59: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share Analysis, by End-user, 2022–2031

    Figure 60: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Type, 2023–2031

    Figure 61: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by Test Method, 2023–2031

    Figure 62: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness Analysis, by End-user, 2023–2031

Copyright © Transparency Market Research, Inc. All Rights reserved